Home

ProMIS Neurosciences Inc. - Common Shares (PMN)

0.9095
+0.0195 (2.19%)

ProMIS Neurosciences Inc. is a biotechnology company focused on developing innovative therapeutic solutions for neurodegenerative diseases, particularly those associated with misfolded proteins such as Alzheimer’s disease

The company utilizes its proprietary protein misfolding technology to create novel antibodies that target specific disease-causing proteins, aiming to improve outcomes for patients suffering from these debilitating conditions. Through its research efforts, ProMIS seeks to advance the understanding of neurodegeneration and provide effective treatments that may alter the course of these diseases.

SummaryNewsPress ReleasesChartHistoricalFAQ
ProMIS Neurosciences And 2 Other Stocks Under $5 Executives Are Buyingbenzinga.com
Via Benzinga · September 19, 2024
Why Exicure Shares Are Trading Higher By Around 180%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · September 19, 2024
Around $2M Bet On This Health Care Stock? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buyingbenzinga.com
Via Benzinga · August 19, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Mondayinvestorplace.com
It's time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today!
Via InvestorPlace · August 12, 2024
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · August 12, 2024
PMN Stock Earnings: ProMIS Neurosciences Beats EPS for Q2 2024investorplace.com
PMN stock results show that ProMIS Neurosciences beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 8, 2024
PMN Stock Earnings: ProMIS Neurosciences Beats EPS for Q1 2024investorplace.com
PMN stock results show that ProMIS Neurosciences beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 15, 2024
Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earningsbenzinga.com
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.89% to 38,321.05 while the NASDAQ rose 0.70% to 16,288.03. The S&P 500 also rose, gaining, 0.80% to 5,164.30.
Via Benzinga · April 15, 2024
PMN Stock Earnings: ProMIS Neurosciences Beats EPS for Q4 2023investorplace.com
PMN stock results show that ProMIS Neurosciences beat analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · April 1, 2024
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Sessionbenzinga.com
Via Benzinga · July 26, 2024
Crude Oil Falls; Dick's Sporting Goods Earnings Miss Viewsbenzinga.com
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling over 100 points on Tuesday. The Dow traded down 0.39% to 34,330.87 while the NASDAQ rose 0.24% to 13,530.50. The S&P 500, also fell, dropping, 0.11% to 4,394.78.
Via Benzinga · August 22, 2023
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Sessionbenzinga.com
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQRARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Via Benzinga · April 15, 2024
Why ProMIS Neurosciences Shares Are Trading Higher By 33%; Here Are 20 Stocks Moving Premarketbenzinga.com
Gainers Axcella Health Inc. (NASDAQAXLA) shares gained 65% to $0.2887 in pre-market trading after gaining 12% on Monday. The company recently posted a narrower-than-expected quarterly loss.
Via Benzinga · August 22, 2023
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Sessionbenzinga.com
Shares of TransCode Therapeutics, Inc. (NASDAQRNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.
Via Benzinga · January 19, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesdayinvestorplace.com
We're starting off Tuesday with a breakdown of the biggest pre-market stock movers investors will want to keep an eye on!
Via InvestorPlace · August 22, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 3, 2023benzinga.com
Via Benzinga · October 3, 2023
Why Macy's Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com
Gainers Fulcrum Therapeutics, Inc. (NASDAQFULC) shares jumped 42.8% to $5.60 after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease.
Via Benzinga · August 22, 2023
Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarketbenzinga.com
Gainers Biophytis S.A. (NASDAQBPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's main product.
Via Benzinga · July 18, 2023
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesdayinvestorplace.com
It's time to start off trading for Tuesday with a breakdown of the biggest pre-market stock movers worth watching this morning.
Via InvestorPlace · July 18, 2023
Crude Oil Falls; GreenPower Motor Company Shares Spike Higherbenzinga.com
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 0.25% on Monday. The Dow traded up 0.25% to 34,596.04 while the NASDAQ rose 0.92% to 14,243.64. The S&P 500, also rose, gaining, 0.43% to 4,524.74.
Via Benzinga · July 17, 2023
Why ProMIS Neurosciences Stock Surged Todaybenzinga.com
ProMIS Neurosciences Inc. (NASDAQPMN) shares skyrocketed Monday after the company presented preclinical data supporting the potential therapeutic advantage of its lead candidate for Alzheimer's disease (AD), PMN310, and additional studies that further characterize a computationally-derived AD vaccine <
Via Benzinga · July 17, 2023
Nasdaq Gains 100 Points; Guaranty Bancshares Posts Upbeat Resultsbenzinga.com
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Monday. The Dow traded up 0.19% to 34,574.01 while the NASDAQ rose 0.71% to 14,214.50. The S&P 500, also rose, gaining, 0.31% to 4,519.25.
Via Benzinga · July 17, 2023
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Sessionbenzinga.com
Gainers ProMIS Neurosciences, Inc. (NASDAQPMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived antibody and vaccine from Alzheimer's pipeline.
Via Benzinga · July 17, 2023
US Stocks Edge Higher; NY Empire State Manufacturing Index Falls In Julybenzinga.com
U.S. stocks traded slightly higher this morning, with the Dow Jones moving higher by around 20 points on Monday. Following the market opening Monday, the Dow traded up 0.06% to 34,529.57 while the NASDAQ rose 0.25% to 14,149.04. The S&P 500, also rose, gaining, 0.06% to 4,508.18.
Via Benzinga · July 17, 2023
Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Sessionbenzinga.com
Gainers Mobilicom Limited (NASDAQMOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the U.S. Department of Defense.
Via Benzinga · July 10, 2023